Immunovant Inc share price logo

Immunovant Inc Share Price

NASDAQ: IMVT

Mid Cap

$24.12

+0.52

(+2.20%)

Live

as on

Immunovant Inc Stock Performance

as on November 7, 2025 at 12:41 am IST

  • Day's Low

    Day's High

    $23.4
    $24.27
    downward going graph

    2.99%

    Downside

    0.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $12.72
    $32.1
    downward going graph

    47.26%

    Downside

    33.08%

    Upside

    downward going graph

Immunovant Inc share price movements today

Previous Close
$23.60
Open
$23.60
Volume
510.2K
Day's Low - High
$23.4 - $24.27
52 Week Low - High
$12.72 - $32.1

Immunovant Inc Historical Returns

1 Month Return
+ 42.6 %
3 Month Return
+ 47.87 %
1 Year Return
-24.89 %
3 Year Return
+ 95.85 %
5 Year Return
-52.25 %

Immunovant Inc Stock Fundamentals & Key Indicators

Check Immunovant Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2B

EPS (TTM)

-2.8739

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-470.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-77.58%

Immunovant Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunovant Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immunovant Inc image
Immunovant Inc
BUY$4.2B-52.25%NA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$39.9B473.78%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$55.9B232.41%1411.571.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$108.1B89.3%29.6331.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$67.5B11.45%15.3832.13%

Stock Returns calculator for Immunovant Inc Stock including INR - Dollar returns

The Immunovant Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Immunovant Inc investment value today

Current value as on today

₹81,802

Returns

₹18,198

(-18.2%)

Returns from Immunovant Inc Stock

₹23,234 (-23.23%)

Dollar Returns*

₹5,036 (+5.04%)

Analyst Recommendation on Immunovant Inc Stock

Based on 22 analysts

BUY

95.45%

Buy

4.55%

Hold

0.00%

Sell

Based on 22 analysts, 95.45% of analysts recommend a 'BUY' rating for Immunovant Inc. Average target price of $38.33

Immunovant Inc Share Price Target

Get share price movements and forecasts by analysts on Immunovant Inc.

What analysts predicted

37.07%UPSIDE

Target Price

$38.33

Current Price

$24.12

Analyzed by

22 Analysts

Target

$38.33

Immunovant Inc target price $38.33, a slight upside of 37.07% compared to current price of $24.12. According to 22 analysts rating.

Immunovant Inc Stock’s Investor Sentiment and Interest

Search interest for Immunovant Inc Stock has increased by 118% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:118% versus previous 30 day period

Immunovant Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
1
-
-
-
0
-
Gross Profit
0
0
0
0
1
0
0
0
0
0
Operating Income
-64
-73
-58
-51
-80
-94
-115
-114
-113
-127
EBITDA
-64
-65
-61
-61
-80
-94
-115
-114
-88
-119
Interest Expense
3
4
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-60
-73
-58
-51
-75
-87
-109
-110
-105
-119
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-59
-73
-58
-51
-75
-87
-109
-111
-106
-120
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-5021.27%
0.00%
0.00%
0.00%
-66530.63%
0.00%

Immunovant Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
-1
-1
0
0
Operating Income
-65
-107
-156
-198
-282
-438
EBITDA
-65
-106
-155
-209
-269
-412
Interest Expense
0
-
0
12
49
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-66
-107
-156
-210
-258
-412
Income Tax Expense
0
0
0
0
0
0
Net Income
-66
-107
-156
-210
-259
-413
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immunovant Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-73
-58
-51
-75
-87
-109
-111
-106
-120
Operating Cash Flow
-47
-60
-47
-59
-76
-88
-100
-110
-117
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
0
0
469
1
0
0
2
450
2
Change in Cash
-46
-60
-321
-55
-75
-87
-98
339
-115

Immunovant Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
0
-28
-66
-107
-156
-210
-259
-413
Operating Cash Flow
-
-28
-53
-83
-106
-188
-214
-375
Investing Cash Flow
-
0
0
0
0
0
0
0
Financing Cash Flow
0
35
146
383
200
70
472
454
Change in Cash
0
6
93
299
93
-117
258
78

Global Institutional Holdings in Immunovant Inc

Funds
Holdings
FMR Inc
10.67%
Deep Track Capital, LP
5.45%
Vanguard Group Inc
4.03%
T. Rowe Price Investment Management,Inc.
3.95%
BlackRock Inc
3.35%
See all

Insights on Immunovant Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, IMVT stock has moved up by 42.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 156.5% return, outperforming this stock by 181.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 926.8% return, outperforming this stock by 830.9%

About Immunovant Inc

immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. it develops imvt-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in phase iia clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of phase ii clinical trials for the treatment of warm autoimmune hemolytic anemia. the company is headquartered in new york, new york. immunovant, inc. is a subsidiary of roivant sciences ltd.
OrganisationImmunovant Inc
Headquarters320 West 37th Street, New York, NY, United States, 10018
IndustryFinance
CEODr. Eric Venker M.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Immunovant Inc

Name

Title

Dr. Frank M. Torti M.B.A., M.D.

Executive Chairperson of the Board

Ms. Melanie Gloria B.S.N.

Chief Operating Officer

Dr. Jay S. Stout M.S., Ph.D.

Chief Technology Officer

Ms. Lauren Schrier M.B.A.

VP & Head of Global Medical Affairs

Dr. Eric Venker M.D., Pharm.D.

CEO & Director

Mr. Christopher A. Van Tuyl Esq., J.D.

Chief Legal Officer & Corporate Secretary

Dr. Michael Geffner M.B.A., M.D., Ph.D.

Chief Medical Officer

Mr. Tiago M. Girao CPA

Chief Financial Officer

Ms. Christine Blodgett

Senior Vice President of Human Resources

Mr. Andy Deig M.B.A.

Senior Vice President of Strategic Finance

FAQs

What is Immunovant Inc share price today?

Immunovant Inc share price today is $24.12 as on . Immunovant Inc share today touched a day high of $24.27 and a low of $23.4.

What is the 52 week high and 52 week low for Immunovant Inc share?

Immunovant Inc share touched a 52 week high of $32.1 on and a 52 week low of $12.72 on . Immunovant Inc stock price today i.e. is trending at $24.12,which is 24.86% down from its 52 week high and 89.62% up from its 52 week low.

What is Immunovant Inc's market capitalisation today?

Immunovant Inc market capitalisation is $0.00T as on .

How to invest in Immunovant Inc Stock (IMVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunovant Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunovant Inc Shares that will get you 0.0622 shares as per Immunovant Inc share price of $24.12 per share as on November 7, 2025 at 12:41 am IST.

What is the minimum amount required to buy Immunovant Inc Stock (IMVT) from India?

Indian investors can start investing in Immunovant Inc (IMVT) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Immunovant Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunovant Inc share’s latest price of $24.12 as on November 7, 2025 at 12:41 am IST, you will get 0.4146 shares of Immunovant Inc. Learn more about fractional shares .

What are the returns that Immunovant Inc has given to Indian investors in the last 5 years?

Immunovant Inc stock has given -52.25% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?